SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Wai-Kay Seto, Man-Fung Yuen, James Fung, Ching-Lung Lai, Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection, Hepatology International, 2013, 7, 2, 327

    CrossRef

  2. 2
    Robert G. Gish, Margaret D. Clark, Steve D. Kane, Richard E. Shaw, Michael F. Mangahas, Sumbella Baqai, Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2012, 10, 8, 941

    CrossRef

  3. 3
    Erik De Clercq, Tenofovir: Quo Vadis Anno 2012 (Where Is It Going in the Year 2012)?, Medicinal Research Reviews, 2012, 32, 4
  4. 4
    M. Lartey, K. Torpey, J.K. Aronson, A worldwide yearly survey of new data in adverse drug reactions, 2011,

    CrossRef

  5. 5
    Vandana Khungar, Steven-Huy Han, A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B, Current Hepatitis Reports, 2010, 9, 2, 75

    CrossRef

  6. 6
    Nancy Crum-Cianflone, Anuradha Ganesan, Nimfa Teneza-Mora, Mark Riddle, Sheila Medina, Irma Barahona, Stephanie Brodine, Prevalence and Factors Associated with Renal Dysfunction Among HIV-Infected Patients, AIDS Patient Care and STDs, 2010, 24, 6, 353

    CrossRef